JP7359772B2 - 検体検出方法 - Google Patents

検体検出方法 Download PDF

Info

Publication number
JP7359772B2
JP7359772B2 JP2020544343A JP2020544343A JP7359772B2 JP 7359772 B2 JP7359772 B2 JP 7359772B2 JP 2020544343 A JP2020544343 A JP 2020544343A JP 2020544343 A JP2020544343 A JP 2020544343A JP 7359772 B2 JP7359772 B2 JP 7359772B2
Authority
JP
Japan
Prior art keywords
sample
cms
blood
samples
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020544343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021503609A (ja
JP2021503609A5 (https=
Inventor
パルツ、ゲイリー
ウー、マンホン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of JP2021503609A publication Critical patent/JP2021503609A/ja
Publication of JP2021503609A5 publication Critical patent/JP2021503609A5/ja
Application granted granted Critical
Publication of JP7359772B2 publication Critical patent/JP7359772B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/150022—Source of blood for capillary blood or interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/0051—Devices for taking samples of body liquids for taking saliva or sputum samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/0058—Devices for taking samples of body liquids for taking sperm samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/0064—Devices for taking samples of body liquids for taking sweat or sebum samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/007—Devices for taking samples of body liquids for taking urine samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B2010/0067—Tear or lachrymal fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B2010/0077—Cerebrospinal fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2503/00—Evaluating a particular growth phase or type of persons or animals
    • A61B2503/04—Babies, e.g. for SIDS detection
    • A61B2503/045—Newborns, e.g. premature baby monitoring
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0627—Sensor or part of a sensor is integrated
    • B01L2300/0636—Integrated biosensor, microarrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/12—Specific details about materials
    • B01L2300/126—Paper

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Clinical Laboratory Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
JP2020544343A 2017-11-01 2018-10-31 検体検出方法 Active JP7359772B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762580277P 2017-11-01 2017-11-01
US62/580,277 2017-11-01
US201862615576P 2018-01-10 2018-01-10
US62/615,576 2018-01-10
PCT/US2018/058440 WO2019089746A1 (en) 2017-11-01 2018-10-31 Analyte detection method

Publications (3)

Publication Number Publication Date
JP2021503609A JP2021503609A (ja) 2021-02-12
JP2021503609A5 JP2021503609A5 (https=) 2021-12-09
JP7359772B2 true JP7359772B2 (ja) 2023-10-11

Family

ID=66332715

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020544343A Active JP7359772B2 (ja) 2017-11-01 2018-10-31 検体検出方法

Country Status (6)

Country Link
US (1) US20210086176A1 (https=)
EP (1) EP3704466B1 (https=)
JP (1) JP7359772B2 (https=)
CN (1) CN111295577A (https=)
CA (1) CA3079837A1 (https=)
WO (1) WO2019089746A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7645285B2 (ja) * 2020-05-19 2025-03-13 サノフイ 乾燥血液サンプルを用いた薬物レベルの検証のためのシステム
CN114740127A (zh) * 2022-05-16 2022-07-12 杭州度安医学检验实验室有限公司 一种基于lc-ms/ms检测5种抗肿瘤药物的试剂盒和方法
CN114994198B (zh) * 2022-05-20 2023-02-28 上海市精神卫生中心（上海市心理咨询培训中心） 一种液相色谱质谱联用法同时定量检测78种神经精神类药物的方法
KR102826451B1 (ko) * 2023-09-01 2025-06-27 사회복지법인 삼성생명공익재단 신생아로부터 비침습적으로 분리된 검체를 이용한 신생아의 검체 분석 방법
CN117783507B (zh) * 2024-02-27 2024-06-04 广州科方生物技术股份有限公司 一种通用于(1-3)-β-D葡聚糖及半乳甘露聚糖检测中组分液及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010515062A (ja) 2006-12-29 2010-05-06 アボット・ラボラトリーズ 非変性細胞溶解試薬
US20120214875A1 (en) 2011-02-22 2012-08-23 Hughes Nicola Christine Phenoxybenzamine assay
JP2016006420A (ja) 2014-05-30 2016-01-14 学校法人東京医科大学 唾液試料の調製方法
WO2016191738A1 (en) 2015-05-27 2016-12-01 Quest Diagnostics Investments Llc Methods for mass spectrometric quantitation of analytes extracted from a microsampling device
JP2017072470A (ja) 2015-10-07 2017-04-13 東芝メディカルシステムズ株式会社 毛細管、試料採取具、及び試料採取器

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503198B1 (en) * 1997-09-11 2003-01-07 Jack L. Aronowtiz Noninvasive transdermal systems for detecting an analyte obtained from or underneath skin and methods
US20010016317A1 (en) * 1999-09-13 2001-08-23 Dolores M. Berger Method for providing long term stability to cells for diagnostic testing
US6916608B2 (en) * 1999-09-10 2005-07-12 Becton, Dickinson And Company Composition for providing long term stability to cells for diagnostic testing
WO2001055701A1 (en) * 2000-01-31 2001-08-02 Board Of Regents, The University Of Texas System System and method for the analysis of bodily fluids
US20030029254A1 (en) * 2001-06-26 2003-02-13 Hvidtfeldt Kristian J. Blood analyzer
US20120003685A1 (en) * 2001-07-19 2012-01-05 Amnon Kritzman Diagnostic composition and article for monitoring intravaginal infections
GB0411387D0 (en) * 2004-05-21 2004-06-23 Chiron Srl Analysis of saccharide length
US20070248628A1 (en) * 2005-12-06 2007-10-25 Keller Lorraine H Immunogens in cancer stem cells
EP2104420A2 (en) * 2006-10-30 2009-09-30 George Mason Intellectual Properties, Inc. Tissue preservation and fixation method
GB0716427D0 (en) * 2007-08-23 2007-10-03 Smartsensor Telemed Ltd Glucose tolerance test device
JP2011513331A (ja) * 2008-02-29 2011-04-28 アレイ バイオファーマ、インコーポレイテッド ピラゾール［３，４−ｂ］ピリジンＲＡＦ阻害剤
IT1397866B1 (it) * 2009-12-23 2013-02-04 Azienda Ospedaliero Universitaria Meyer Metodo e kit per la determinazione di metaboliti su campioni di sangue depositato su carta bibula (dried blood spot).
CN102713619B (zh) * 2009-12-23 2018-08-10 塞尔雷斯蒂斯有限公司 测量细胞介导免疫反应的试验
CA2766635C (en) * 2011-02-04 2019-08-06 Phytronix Technologies Inc. Sample preparation for mass spectrometry analysis systems
TW201741663A (zh) * 2011-12-29 2017-12-01 陶氏農業科學公司 利用鹼皂化作用來對植物組織樣本總油含量進行比色測定之技術
WO2014150900A1 (en) * 2013-03-15 2014-09-25 Baylor Research Institute Methods and compositions for enhanced analyte detection from blood
WO2016011798A1 (zh) * 2015-01-27 2016-01-28 深圳华大基因研究院 用于保存生物样品的稳定剂
WO2016134324A1 (en) * 2015-02-20 2016-08-25 Neoteryx, Llc Method and apparatus for acquiring blood for testing
EP3139171B1 (en) * 2015-09-02 2020-02-12 Labsystems Diagnostics Oy Novel methods and kits for detecting of urea cycle disorders using mass spectrometry
WO2017165630A1 (en) * 2016-03-23 2017-09-28 Truvian Sciences, Inc. Systems and methods for multianalyte detection

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010515062A (ja) 2006-12-29 2010-05-06 アボット・ラボラトリーズ 非変性細胞溶解試薬
US20120214875A1 (en) 2011-02-22 2012-08-23 Hughes Nicola Christine Phenoxybenzamine assay
JP2016006420A (ja) 2014-05-30 2016-01-14 学校法人東京医科大学 唾液試料の調製方法
WO2016191738A1 (en) 2015-05-27 2016-12-01 Quest Diagnostics Investments Llc Methods for mass spectrometric quantitation of analytes extracted from a microsampling device
JP2017072470A (ja) 2015-10-07 2017-04-13 東芝メディカルシステムズ株式会社 毛細管、試料採取具、及び試料採取器

Also Published As

Publication number Publication date
WO2019089746A1 (en) 2019-05-09
US20210086176A1 (en) 2021-03-25
EP3704466A4 (en) 2021-08-11
CN111295577A (zh) 2020-06-16
EP3704466B1 (en) 2023-10-11
JP2021503609A (ja) 2021-02-12
EP3704466A1 (en) 2020-09-09
CA3079837A1 (en) 2019-05-09

Similar Documents

Publication Publication Date Title
JP7359772B2 (ja) 検体検出方法
Lin et al. Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS
Kameda et al. Reduced uremic metabolites are prominent feature of sarcopenia, distinct from antioxidative markers for frailty
Tsoukalas et al. Application of metabolomics: Focus on the quantification of organic acids in healthy adults
Heltsley et al. Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens
Green Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies
JP6021187B2 (ja) 自閉症の代謝バイオマーカー
Kapur et al. What the lab can and cannot do: clinical interpretation of drug testing results
ES2927921T3 (es) Métodos que utilizan paneles de metabolitos para el diagnóstico y diferenciación de la encefalopatía neonatal
US11412953B2 (en) Diagnosis of asthma versus chronic obstructive pulmonary disease (COPD) using urine metabolomic analysis
WO2017003936A1 (en) Methods for detecting, diagnosing and treating endometrial cancer
Mandour et al. Amino acid and acylcarnitine profiles in premature neonates: a pilot study
Lehikoinen et al. Alcohol and substance use are associated with altered metabolome in the first trimester serum samples of pregnant mothers
WO2017003941A1 (en) Methods for detecting, diagnosing and treating traumatic brain injury
JP2023543730A (ja) 自閉症スペクトラム障害の診断及び治療方法
Patel et al. Improved detection and precise relative quantification of the urinary cancer metabolite biomarkers–Creatine riboside, creatinine riboside, creatine and creatinine by UPLC-ESI-MS/MS: Application to the NCI-Maryland cohort population controls and lung cancer cases
Rizzo et al. Measurement of succinyl-carnitine and methylmalonyl-carnitine on dried blood spot by liquid chromatography-tandem mass spectrometry
Flint et al. Simultaneous quantification of fentanyl, sufentanil, cefazolin, doxapram and keto‐doxapram in plasma using liquid chromatography–tandem mass spectrometry
Ye et al. Clinical significance of serum homocysteine as a biomarker for early diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients
Kozioł et al. Application of metabolomics in childhood leukemia diagnostics
Gupta et al. Metabolomics of neurological disorders in India
Janzen et al. UPLC–MS/MS analysis of C5-acylcarnitines in dried blood spots
Zheng et al. Metabolic signature of pregnant women with neural tube defects in offspring
van der Ham et al. Suitability of methylmalonic acid and total homocysteine analysis in dried bloodspots
Godlewski et al. Metabolomic profiling of plasma from glioma and meningioma patients based on two complementary mass spectrometry techniques

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211028

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211028

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20221018

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230123

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230413

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230623

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230905

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230928

R150 Certificate of patent or registration of utility model

Ref document number: 7359772

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150